Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16304073rdf:typepubmed:Citationlld:pubmed
pubmed-article:16304073lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16304073lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:16304073lifeskim:mentionsumls-concept:C0948089lld:lifeskim
pubmed-article:16304073lifeskim:mentionsumls-concept:C0019134lld:lifeskim
pubmed-article:16304073lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:16304073lifeskim:mentionsumls-concept:C0439231lld:lifeskim
pubmed-article:16304073lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:16304073lifeskim:mentionsumls-concept:C0332293lld:lifeskim
pubmed-article:16304073pubmed:issue20lld:pubmed
pubmed-article:16304073pubmed:dateCreated2005-11-23lld:pubmed
pubmed-article:16304073pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16304073pubmed:abstractTextThe SYNERGY trial comparing enoxaparin and unfractionated heparin in high-risk patients with acute coronary syndromes (ACS) showed that enoxaparin was not inferior to unfractionated heparin in reducing death or nonfatal myocardial infarction (MI) at 30 days.lld:pubmed
pubmed-article:16304073pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16304073pubmed:languageenglld:pubmed
pubmed-article:16304073pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16304073pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16304073pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16304073pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16304073pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16304073pubmed:statusMEDLINElld:pubmed
pubmed-article:16304073pubmed:monthNovlld:pubmed
pubmed-article:16304073pubmed:issn1538-3598lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:WhiteHarvey...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:CaliffRobert...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:CohenMarcMlld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:KleimanNeal...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:GoodmanShaun...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:MahaffeyKenne...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:BerdanLisa...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:AylwardPhilip...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:LangerAnatoly...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:FergusonJames...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:ColJacques...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:AntmanElliott...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:SYNERGY...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:ReistCraig...lld:pubmed
pubmed-article:16304073pubmed:authorpubmed-author:GargJyotsnaJlld:pubmed
pubmed-article:16304073pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16304073pubmed:day23lld:pubmed
pubmed-article:16304073pubmed:volume294lld:pubmed
pubmed-article:16304073pubmed:ownerNLMlld:pubmed
pubmed-article:16304073pubmed:authorsCompleteYlld:pubmed
pubmed-article:16304073pubmed:pagination2594-600lld:pubmed
pubmed-article:16304073pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:meshHeadingpubmed-meshheading:16304073...lld:pubmed
pubmed-article:16304073pubmed:year2005lld:pubmed
pubmed-article:16304073pubmed:articleTitleHigh-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.lld:pubmed
pubmed-article:16304073pubmed:affiliationDuke Clinical Research Institute, Durham, NC 27715, USA. mahaf002@mc.duke.edulld:pubmed
pubmed-article:16304073pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16304073pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:16304073pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16304073lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16304073lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16304073lld:pubmed